Extremely oblique sclerotomy incision reduces wound leakage in vitrectomy

Article

Extremely oblique sclerotomy incision (OSI) has a self-sealing effect on sclerotomy wound leakages.

Extremely oblique sclerotomy incision (OSI) has a self-sealing effect on sclerotomy wound leakages, says an investigation published in Retina.

The nested case-control study, led by Dr Albert L. Lin, Department of Ophthalmology, Cullen Eye Institute, Houston, Texas, USA, involved 48 patients with wound leaks and 171 control patients without leaks. Patients received either a conventional sclerotomy incision of 45°, changed to 90° midincision, or an OSI at 10°, changed to 30° midincision.

Age, gender, laterality, duration of surgery, preoperative diagnosis, vitrectomy history, sclerotomy incision and primary surgeon were the risk factors investigated.

After using multivariate logistic regression analysis it was discovered that OSI, macular preoperative diagnosis, surgical duration, no previous vitrectomy, and female gender were the protective factors for wound leakage. Using OSI compared to a standard sclerotomy incision reduces the chance of wound leakage.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.